News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Patrizia Giannatempo: Great day focused on Advanced Urothelial Cancer – new approaches in NMIBC
Patrizia Giannatempo/X
May 11, 2025, 07:04

Patrizia Giannatempo: Great day focused on Advanced Urothelial Cancer – new approaches in NMIBC

Patrizia Giannatempo, Medical Oncology Consultant at the National Cancer Institute (INT) in Milan, posted on X:

“Great day focused on aUC: new approaches in NMIBC, first-line treatments, and emerging drugs—under the beautiful Lisbon sky.
Fantastic atmosphere with a super company.”

Patrizia Giannatempo: Great day focused on Advanced Urothelial Cancer - new approaches in NMIBC

More posts featuring Patrizia Giannatempo.

AUC cancer NMIBC OncoDaily Oncology Patrizia Giannatempo urothelial cancer
Special Coverage
Blog
Jun 1, 2025, 05:07
Jason Westin Urges Action Against Proposed Federal Cuts to Cancer Research Funding
Blog
Jun 1, 2025, 04:58
Yan Leyfman: Excited to Present Research on GLP-1 Receptor Agonists at ASCO 2025
Blog
Jun 1, 2025, 04:53
Erika Hamilton: Highlights from Me at Day 2 of ASCO25
Oncolibrary
Jun 1, 2025, 04:52
BREAKWATER Trial: New Standard for BRAF V600E Metastatic Colorectal Cancer at ASCO 2025
Blog
Jun 1, 2025, 04:47
National Cancer Institute of Kenya - Major Breakthrough in Breast Cancer Treatment Costs in Kenya
Blog
Jun 1, 2025, 04:39
Guillermo Chantada: SIOP and ISOO Sign Agreement to Advance Retinoblastoma Care Globally
Opinion
Jun 1, 2025, 04:14
Every Trial Gives Hope: Tian Zhang Shared Reflections Ahead of ASCO 2025
Insight
Jun 1, 2025, 04:10
Paolo Tarantino: Impressive Phase 2 Data with the Trop2 ADC Sac-TMT for 1L mTNBC at ASCO 2025
Insight
Jun 1, 2025, 04:01
Kunal Jobanputra: Our Abstract on Metastatic Pancreatic Cancer in Western India Published in JCO
Oncolibrary
Jun 1, 2025, 03:54
POLCAGB Results at ASCO 2025: Concurrent Chemoradiation Plus Chemotherapy Improves Survival and Resection Outcomes in Locally Advanced Gallbladder Cancer
Oncolibrary
Jun 1, 2025, 03:54
INAVO120 Trial Final OS Analysis: INAVO Plus Palbociclib and Fulvestrant Improves Survival in PIK3CA-Mutated HR+/HER2– Advanced Breast Cancer
Career
Jun 1, 2025, 03:45
Enrique Soto: Honored to Receive the Conquer Cancer, the ASCO Foundation Advanced Clinical Research Award